Status:
UNKNOWN
Research on a NTHF to Improve Pulmonary Function in Patients With Respiratory Failure
Lead Sponsor:
Shenzhen Second People's Hospital
Conditions:
Respiratory Insufficiency
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients with respiratory failure have high morbidity and mortality. Long-term mechanical ventilation causes a high medical burden and cannot cure respiratory failure. Therefore, in-depth research on ...
Detailed Description
1.1 Patients with respiratory failure have high morbidity and mortality. Long-term mechanical ventilation causes a high medical burden and cannot cure respiratory failure. Therefore, it is necessary t...
Eligibility Criteria
Inclusion
- Patient who ≥18 years old and meets the diagnostic criteria for respiratory failure
- Have an artificial airway, ready or have been released from the ventilator
- The circulation is basically stable, and there are no shocks of various types that are difficult to correct (mean arterial pressure remains unchanged under the condition of vasoactive drugs).
- \<65mmHg)
- Consciousness and ability to cooperate with clinical treatment
Exclusion
- Pregnancy and end-stage cancer patients
- History of airway injury, pulmonary trauma, and lung surgery
- Central respiratory failure or status asthmaticus caused by neurological diseases
- Refusing to cooperate with treatment or to participate in the researcher
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT05435079
Start Date
July 1 2022
End Date
June 30 2024
Last Update
June 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shenzhen Second People's Hospital
Shenzhen, Guangdong, China, 518000